Trends in Adolescent Completed Suicide in Croatia for the Period of 2000 to 2020.

BACKGROUND: Croatia belongs to the countries with a medium mortality rate due to suicide in youths. Previous epidemiological reports indicated a decreasing trend of suicide rates in adolescents. However, recent trend analysis in youth suicide rates in Croatia are missing. This study aimed to describe recent trends in child and adolescent completed suicide in Croatia and to compare the rates and methods of suicide ("means") across demographic groups. SUBJECTS AND METHODS: Data from the Croatian Committed Suicide Registry were used to calculate age-specific rates of suicide from 2000 to 2020 among 0 to 24 year olds, overall and by age, gender, and means of suicide. RESULTS: The total average suicide rate for Croatian children and adolescents during the study period was 4.12 per 100,000. The male-female ratio was 4.1:1. The total youth suicide rate and male suicide rate significantly declined from 2000 to 2020; however, the decrease in female rates did not reach statistical significance. Nearly half of all suicides among Croatian youth of both gender occurred through hanging, whereas using firearms was the second-most common suicide method in males and jumping from a height in females. CONCLUSIONS: Suicide rates among children and adolescents in Croatia continue to decrease. High-risk groups include adolescents aged 20-24 years and male youth, so these data should be considered when designing prevention programmes for youth suicide.

Two-year rehospitalization rates of patients with newly diagnosed or chronic schizophrenia on atypical or typical antipsychotic drugs: retrospective cohort study.

AIM: To determine if atypical antipsychotic agents reduce the rehospitalization rates of patients with newly diagnosed or chronic schizophrenia in comparison with typical antipsychotic drugs. METHODS: From January 1, 2003, to December 31, 2004, we retrospectively compared two-year rehospitalization rates of 135 patients with newly diagnosed schizophrenia and 398 patients with chronic schizophrenia (62% and 65% men, respectively), who were initially discharged from Vrapce Psychiatric Hospital, Zagreb, with the prescription of atypical (olanzapine, risperidone or clozapine) or typical (haloperidol or fluphenazine) antipsychotic treatment between January 1, 2002 and December 31, 2002. Time-to-readmission was determined with Kaplan-Meier formula for survival analysis. RESULTS: In the two-year follow-up, 52 (39%) newly diagnosed patients and 197 (47%) patients with chronic schizophrenia were rehospitalized. No significant differences in time-to-rehospitalization were observed with respect to the type of medications in patients with newly diagnosed schizophrenia (P=0.378) or patients with chronic schizophrenia (P=0.531). CONCLUSIONS: Rehospitalization rates of patients who were prescribed atypical antipsychotic drugs were similar to those of patients who were prescribed typical antipsychotic drugs for both the group with the first psychotic episode and group with chronic schizophrenia.